Mather Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Sell
9,132
-1,559
-15% -$1.59M 0.1% 100
2026
Q1
$9.83M Buy
10,691
+596
+6% +$604K 0.1% 87
2025
Q4
$10.8M Buy
10,095
+2,250
+29% +$2.15M 0.11% 81
2025
Q3
$5.99M Buy
7,845
+75
+1% +$55.8K 0.06% 112
2025
Q2
$6.06M Sell
7,770
-604
-7% -$469K 0.06% 109
2025
Q1
$6.92M Buy
8,374
+982
+13% +$817K 0.08% 97
2024
Q4
$5.71M Buy
7,392
+405
+6% +$335K 0.07% 105
2024
Q3
$6.19M Sell
6,987
-272
-4% -$245K 0.08% 104
2024
Q2
$5.65M Sell
7,259
-145
-2% -$116K 0.07% 115
2024
Q1
$4.32M Buy
7,404
+2
+0% +$1.42K 0.07% 99
2023
Q4
$4.32M Sell
7,402
-280
-4% -$163K 0.07% 102
2023
Q3
$4.13M Sell
7,682
-558
-7% -$288K 0.07% 98
2023
Q2
$3.86M Buy
8,240
+657
+9% +$276K 0.06% 113
2023
Q1
$2.6M Buy
7,583
+2,395
+46% +$808K 0.05% 129
2022
Q4
$1.9M Buy
5,188
+588
+13% +$208K 0.04% 142
2022
Q3
$1.49M Sell
4,600
-43
-0.9% -$13.6K 0.03% 152
2022
Q2
$1.5M Buy
4,643
+500
+12% +$150K 0.03% 147
2022
Q1
$1.19M Sell
4,143
-1,902
-31% -$489K 0.02% 152
2021
Q4
$1.67M Buy
6,045
+1,109
+22% +$281K 0.03% 108
2021
Q3
$1.14M Buy
4,936
+385
+8% +$95K 0.03% 107
2021
Q2
$1.04M Buy
4,551
+1,863
+69% +$374K 0.03% 105
2021
Q1
$502K Buy
+2,688
New +$526K 0.01% 150

Other funds holding LLY

Mather Group's LLY Position: Q2 2026 in Review

Mather Group reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $1.59M and leaving 9,132 shares worth $11M. The position accounts for 0.1% of the portfolio, ranked #100.

Mather Group first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mather Group held 9,132 shares of Eli Lilly worth $11M as of Q2 2026.
  • Mather Group sold 1,559 Eli Lilly shares in Q2 2026, an estimated $1.59M.
  • Eli Lilly made up 0.1% of Mather Group's portfolio in Q2 2026, its #100 holding.
  • Mather Group first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.